SCHEMBL7555246

SCHEMBL7555246

CS(=O)(=O)N1CCSc2cccc(F)c2C1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RYR2 Q92736 2/20 0.48
HTT P42858 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.42
ALDH1A1 P00352 1/20 0.42
TSHR P16473 2/20 0.39
TP53 P04637 1/20 0.39
PKM P14618 1/20 0.38
PKLR P30613 1/20 0.38
F12 P00748 2/20 0.35
RBP4 P02753 2/20 0.35
F2 P00734 1/20 0.35
KDM1A O60341 1/20 0.34
NOTUM Q6P988 1/20 0.33
GAA P10253 1/20 0.33
ATM Q13315 1/20 0.33
KCNK3 O14649 3/20 0.33
CCNT1 O60563 1/20 0.33
CDK9 P50750 1/20 0.33
RORC P51449 1/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7581722 0.84 RYR2 (0.49) RYR2HTTALDH1A1TSHRTP53
SCHEMBL7555406 0.83 RYR2 (0.48) RYR2SMN1; SMN2ALDH1A1TSHRF12
SCHEMBL7559963 0.76 RYR2 (0.63) RYR2ALDH1A1KDM1ANOTUMMEN1
SCHEMBL7559448 0.74 NOTUM (0.46) RYR2HTTNOTUMKCNK3
SCHEMBL7556815 0.70 GAA (0.40) RYR2SMN1; SMN2ALDH1A1TSHRTP53
SCHEMBL31424250 0.67 HPGD (0.36) RYR2ALDH1A1NOTUMGAAMEN1
SCHEMBL26344323 0.67 RYR2 (0.71) RYR2TSHR
SCHEMBL7557030 0.64 RYR2 (0.53) RYR2ALDH1A1GAAMEN1KMT2A
Hydrochloric Acid SCHEMBL8528982 0.63 RYR2 (0.51) RYR2ALDH1A1GAAMEN1KMT2A
SCHEMBL7558332 0.63 RYR2 (0.53) RYR2HTTALDH1A1NOTUMKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218010-A2 1,4-BENZOTHIAZEPINES TO TREAT OBESITY RELATED DISORDERS Knoll GmbH (DE) 2002-07-03 EP claimed
WO-2001000185-A2 1,4-DENZOTHIAZEPINES TO TREAT OBESITY RELATED DISORDERS KNOLL GMBH (DE) 2001-01-04 WO claimed
EP-0667866-B1 1,4-BENZOTHIAZEPINES USEFUL AS NEUROLOGICAL AGENTS KNOLL AG (DE) 1998-03-11 EP claimed
US-5580866-A Therapeutic 1,4-thiazepines THE BOOTS COMPANY PLC (GB) 1996-12-03 US claimed
EP-0667866-A1 1,4-BENZOTHIAZEPINES USEFUL AS NEUROLOGICAL AGENTS Knoll AG (DE) 1995-08-23 EP claimed
WO-1994011360-A1 1,4-BENZOTHIAZEPINES USEFUL AS NEUROLOGICAL AGENTS THE BOOTS COMPANY PLC (GB) 1994-05-26 WO claimed
EP-1218010-A2 1,4-BENZOTHIAZEPINES TO TREAT OBESITY RELATED DISORDERS Knoll GmbH (DE) 2002-07-03 EP disclosed
WO-2001000185-A2 1,4-DENZOTHIAZEPINES TO TREAT OBESITY RELATED DISORDERS KNOLL GMBH (DE) 2001-01-04 WO disclosed
EP-0667866-B1 1,4-BENZOTHIAZEPINES USEFUL AS NEUROLOGICAL AGENTS KNOLL AG (DE) 1998-03-11 EP disclosed
US-5580866-A Therapeutic 1,4-thiazepines THE BOOTS COMPANY PLC (GB) 1996-12-03 US disclosed
EP-0667866-A1 1,4-BENZOTHIAZEPINES USEFUL AS NEUROLOGICAL AGENTS Knoll AG (DE) 1995-08-23 EP disclosed
WO-1994011360-A1 1,4-BENZOTHIAZEPINES USEFUL AS NEUROLOGICAL AGENTS THE BOOTS COMPANY PLC (GB) 1994-05-26 WO disclosed